RxDoctor Payments DataLook up a doctor →

Barry Migicovsky, MD

Gastroenterology · Boulder, CONPI 1316948797

Payments from drug & device makers

$208,765in general payments, 2019–2025

Across 854 payments — averaging $244.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Madrigal Pharmaceuticals$67K
  • Gilead$61K
  • AbbVie$35K
  • Phathom Pharmaceuticals, Inc.$28K
  • Intercept Pharmaceuticals, Inc.$5K
  • Merck$3K
  • plus $10K from 34 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Madrigal Pharmaceuticals75$67,248
Gilead151$61,047
AbbVie(2 entities)162$35,261
Phathom Pharmaceuticals, Inc.59$27,581
Intercept Pharmaceuticals, Inc.27$5,296
Merck8$2,809
Olympus Corporation4$2,310
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC59$1,045
Johnson & Johnson51$939
Sanofi30$694
QOL Medical, LLC39$600
Takeda Pharmaceuticals U.S.A., Inc.19$419
Bristol Myers Squibb29$349
Ardelyx, Inc.16$327
Ferring Pharmaceuticals Inc.18$245
Ipsen Biopharmaceuticals, Inc9$244
Medtronic2$235
Celltrion USA Inc.5$232
Regeneron Healthcare Solutions, Inc.10$230
Pfizer11$222
Lilly USA, LLC9$191
Ironwood Pharmaceuticals, Inc13$148
Braintree Laboratories, Inc.9$136
Novo Nordisk5$131
E.r. Squibb & Sons, L.L.C.1$125
Aimmune Therapeutics, Inc.4$110
Daiichi Sankyo Inc.5$106
Shionogi Inc3$72
Dova Pharmaceuticals3$67
Amgen2$48
Olympus America Inc.2$48
Redhill Biopharma Inc.3$41
Nestle Healthcare Nutrition Inc.2$39
Vivus LLC2$37
Endo Pharmaceuticals Inc.2$33
Pharmacosmos Therapeutics Inc.1$25
Alfasigma USA, Inc.1$21
Evoke Pharma, Inc.1$19
UCB, Inc.1$18
Micro-tech Endoscopy USA, Inc.1$17

How this compares

$208,765 in reported general payments places this provider in the 90th percentile of 304 gastroenterology providers in Colorado.

See all gastroenterology providers in Colorado →

Medicare billing

Part B allowed, 2024
$169,139
Medicare patients
396
Services billed
2,641

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Boulder

See the full list for Colorado →

Where these figures come from

Is this you, or does something look wrong? →